Foliculin-75 HP

Foliculin-75 HP



BSV Bioscience Phils


Concise Prescribing Info
Used similarly to human menopausal gonadotropins in treatment of female infertility stimulating development of multiple oocytes w/ the exception that being w/o LH activity. Used in patients where an increase in LH activity not required, as in polycystic ovarian disease (PCOD).
Dosage/Direction for Use
Individualized dosage. Initially 75 IU/day IM for 7-12 days followed by HCG 5,000-10,000 IU 1 day after last dose. May repeat for at least ≥2 courses before increasing to 150 IU/day for 7-12 days, followed by 5,000-10,000 IU 1 day after the last dose. In vitro fertilization 150 IU/day initiated in early follicular phase (cycle day 2 or 3). Duration: Not >10 days.
Hypersensitivity. Women who exhibit high levels of FSH, indicating primary ovarian failure, uncontrolled thyroid or adrenal dysfunction, organic intracranial lesion eg, pituitary tumor, presence of any cause of infertility other than anovulation (unless candidate for in vitro fertilization), ovarian cysts or enlargement not due to polycystic ovarian disease. Pregnancy.
Special Precautions
Close monitoring of ovarian response (risk of overstimulation). Do not administer if ovaries are abnormally enlarged on last day of therapy.
MIMS Class
Trophic Hormones & Related Synthetic Drugs
ATC Classification
G03GA04 - urofollitropin ; Belongs to the class of gonadotropins. Used as ovulation stimulants.
Foliculin-75 HP lyophilized powd for inj 75 IU
(+ 1 mL diluent (amp)) 2 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in